• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mammographic screening: measurement of the cost in a population based programme in Victoria, Australia.乳腺钼靶筛查:澳大利亚维多利亚州一项基于人群的项目中的成本测算
J Epidemiol Community Health. 1994 Aug;48(4):391-9. doi: 10.1136/jech.48.4.391.
2
Measurement of the costs in two mammographic screening programmes in the province of Florence, Italy.意大利佛罗伦萨省两项乳腺钼靶筛查项目的成本测算
J Med Screen. 1995;2(4):191-4. doi: 10.1177/096914139500200404.
3
Effectiveness, costs, and cost-effectiveness of recruitment strategies for a mammographic screening program to detect breast cancer.一项用于检测乳腺癌的乳腺钼靶筛查项目招募策略的有效性、成本及成本效益
J Natl Cancer Inst. 1992 Jun 3;84(11):855-63. doi: 10.1093/jnci/84.11.855.
4
A cost utility analysis of mammography screening in Australia.
Soc Sci Med. 1992 May;34(9):993-1004. doi: 10.1016/0277-9536(92)90130-i.
5
Mammography screening: an incremental cost effectiveness analysis of two view versus one view procedures in London.乳房X线筛查:伦敦地区双视图与单视图检查程序的增量成本效益分析
J Epidemiol Community Health. 1995 Feb;49(1):70-8. doi: 10.1136/jech.49.1.70.
6
The costs of mammography screening in New Zealand: evidence from the pilot programmes.新西兰乳腺钼靶筛查的成本:来自试点项目的证据。
N Z Med J. 1994 Dec 14;107(991):501-3.
7
Cost-effectiveness of breast cancer screening in women on dialysis.透析女性乳腺癌筛查的成本效益
Am J Kidney Dis. 2008 Nov;52(5):916-29. doi: 10.1053/j.ajkd.2008.06.015. Epub 2008 Sep 11.
8
A mammographic screening pilot project in Victoria 1988-1990. The Essendon Breast X-ray Program Collaborative Group.1988 - 1990年在维多利亚开展的一项乳房X光筛查试点项目。埃森顿乳房X光检查项目协作组。
Med J Aust. 1992 Nov 16;157(10):670-3. doi: 10.5694/j.1326-5377.1992.tb137433.x.
9
Counting the costs of mammography screening: first year results from the Sydney study.计算乳腺钼靶筛查的成本:悉尼研究的第一年结果。
Med J Aust. 1990 May 7;152(9):466, 469-71.
10
Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.辅助诊断检测以减少筛查性乳房 X 光摄影后的不必要活检的性能目标:成本、效益和后果分析。
J Am Coll Radiol. 2013 Dec;10(12):924-30. doi: 10.1016/j.jacr.2013.09.009.

本文引用的文献

1
Breast cancer screening and health service costs.乳腺癌筛查与医疗服务成本。
J Health Econ. 1982 Aug;1(2):185-207. doi: 10.1016/0167-6296(82)90014-5.
2
The distinction between cost and charges.成本与收费之间的区别。
Ann Intern Med. 1982 Jan;96(1):102-9. doi: 10.7326/0003-4819-96-1-102.
3
Cost-effectiveness of primary and secondary prevention of fatal pulmonary embolism in high-risk surgical patients.高危手术患者致命性肺栓塞一级和二级预防的成本效益
Can Med Assoc J. 1982 Nov 15;127(10):990-5.
4
A note on the cost-benefit problem in screening for breast cancer.关于乳腺癌筛查中成本效益问题的一则注释
Methods Inf Med. 1972 Oct;11(4):242-7.
5
Screening for breast cancer.乳腺癌筛查
Ann Intern Med. 1989 Sep 1;111(5):389-99. doi: 10.7326/0003-4819-111-5-389.
6
The cost-effectiveness of breast cancer screening.乳腺癌筛查的成本效益
Int J Cancer. 1989 Jun 15;43(6):1055-60. doi: 10.1002/ijc.2910430617.
7
Screening: the need for a population register.筛查:建立人口登记册的必要性。
Med J Aust. 1990 Sep 17;153(6):310-1. doi: 10.5694/j.1326-5377.1990.tb136935.x.
8
On the Oregon trail: rationing health care.在俄勒冈小道上:医疗保健配给
BMJ. 1991 Jan 5;302(6767):1-2. doi: 10.1136/bmj.302.6767.1.
9
Personal costs incurred by women attending a mammographic screening programme.参加乳房X光筛查项目的女性所产生的个人费用。
Med J Aust. 1991 Jan 21;154(2):132-4. doi: 10.5694/j.1326-5377.1991.tb121001.x.
10
Effectiveness, costs, and cost-effectiveness of recruitment strategies for a mammographic screening program to detect breast cancer.一项用于检测乳腺癌的乳腺钼靶筛查项目招募策略的有效性、成本及成本效益
J Natl Cancer Inst. 1992 Jun 3;84(11):855-63. doi: 10.1093/jnci/84.11.855.

乳腺钼靶筛查:澳大利亚维多利亚州一项基于人群的项目中的成本测算

Mammographic screening: measurement of the cost in a population based programme in Victoria, Australia.

作者信息

Hurley S F, Livingston P M, Thane N, Quang L

机构信息

Cancer Epidemiology Centre, Anti-Cancer Council of Victoria, Australia.

出版信息

J Epidemiol Community Health. 1994 Aug;48(4):391-9. doi: 10.1136/jech.48.4.391.

DOI:10.1136/jech.48.4.391
PMID:7964340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1059990/
Abstract

STUDY OBJECTIVES

To estimate the cost per woman participating in a mammographic screening programme, and to describe methods for measuring costs.

DESIGN

Expenditure, resource usage, and throughput were monitored over a 12 month period. Unit costs for each phase of the screening process were estimated and linked with the probabilities of each screening outcome to obtain the cost per woman screened and the cost per breast cancer detected.

SETTING

A pilot, population based Australian programme offering free two-view mammographic screening.

PARTICIPANTS

A total of 5986 women aged 50-69 years who lived in the target area, were listed on the electoral roll, had no previous breast cancer, and attended the programme.

RESULTS

Unit costs for recruitment, screening, and recall mammography were $17.54, $60.04, and $175.54, respectively. The costs of clinical assessment for women with subsequent clear, benign, malignant (palpable), and malignant (impalpable) diagnoses were $173.71, $527.29, $436.62, and $567.22, respectively. The cost per woman screened was $117.70, and the cost per breast cancer detected was $11,550.

CONCLUSIONS

The cost per woman screened is a key variable in assessment of the cost effectiveness of mammographic screening, and is likely to vary between health care settings. Its measurement is justified if decisions about health care services are to be based on cost effectiveness criteria.

摘要

研究目的

估算参与乳腺钼靶筛查项目的每位女性的成本,并描述成本测量方法。

设计

在12个月期间监测支出、资源使用和工作量。估算筛查过程各阶段的单位成本,并将其与每种筛查结果的概率相关联,以得出每位接受筛查女性的成本以及每例检测出的乳腺癌的成本。

背景

一项基于澳大利亚人群的试点项目,提供免费的双视角乳腺钼靶筛查。

参与者

共有5986名年龄在50 - 69岁之间、居住在目标区域、登记在选民名单上、既往无乳腺癌且参加了该项目的女性。

结果

招募、筛查和召回钼靶检查的单位成本分别为17.54美元、60.04美元和175.54美元。后续诊断为明确、良性、恶性(可触及)和恶性(不可触及)的女性的临床评估成本分别为173.71美元、527.29美元、436.62美元和567.22美元。每位接受筛查女性的成本为117.70美元,每例检测出的乳腺癌的成本为11550美元。

结论

每位接受筛查女性的成本是评估乳腺钼靶筛查成本效益的关键变量,且可能因医疗保健环境而异。如果要根据成本效益标准做出关于医疗保健服务的决策,那么对其进行测量是合理的。